The Association Between Biomarkers and Clinical Outcomes in Novel Coronavirus Pneumonia in A Us Cohort
Shant Ayanian, Juan Reyes, Lei Lynn, Karolyn Teufel
Abstract
Laboratory markers of inflammation and coagulopathy can help clinicians identify patients who are at high risk for clinical deterioration in COVID-19.
Topics & Concepts
MedicineRetrospective cohort studyCohortEmergency medicinePneumoniaIntensive care unitCoronavirus disease 2019 (COVID-19)Internal medicineOdds ratioCohort studyIntensive care medicineDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19Vitamin C and Antioxidants Research